Search Results - "Freier, Sue"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Intracerebral Infusion of Antisense Oligonucleotides Into Prion-infected Mice by Nazor Friberg, Karah, Hung, Gene, Wancewicz, Ed, Giles, Kurt, Black, Chris, Freier, Sue, Bennett, Frank, DeArmond, Stephen J, Freyman, Yevgeniy, Lessard, Pierre, Ghaemmaghami, Sina, Prusiner, Stanley B

    Published in Molecular therapy. Nucleic acids (01-02-2012)
    “…Mice deficient for the cellular prion protein (PrPC) do not develop prion disease; accordingly, gene-based strategies to diminish PrPC expression are of…”
    Get full text
    Journal Article
  2. 2

    Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice by Guo, Shuling, Casu, Carla, Gardenghi, Sara, Booten, Sheri, Aghajan, Mariam, Peralta, Raechel, Watt, Andy, Freier, Sue, Monia, Brett P, Rivella, Stefano

    Published in The Journal of clinical investigation (01-04-2013)
    “…β-Thalassemia and HFE-related hemochromatosis are 2 of the most frequently inherited disorders worldwide. Both disorders are characterized by low levels of…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Suppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotides by Ackermann, Elizabeth J., Guo, Shuling, Benson, Merrill D., Booten, Sheri, Freier, Sue, Hughes, Steven G., Kim, Tae-Won, Jesse Kwoh, T., Matson, John, Norris, Dan, Yu, Rosie, Watt, Andy, Monia, Brett P.

    Published in Amyloid (01-09-2016)
    “…Transthyretin amyloidosis (ATTR amyloidosis) is a rare disease that results from the deposition of misfolded transthyretin (TTR) protein from the plasma into…”
    Get full text
    Journal Article
  5. 5

    Trends in Financial Toxicity for Patients of a Community Cancer Clinic by Santhosh-Kumar, Cherupolil R., Struve, Stephanie, Freier, Sue

    Published in Blood (03-12-2015)
    “…Background: Rising health care costs - especially those of new medications for cancer treatment - have caused a severe financial strain on patients, leading to…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Targeting KLF1 for the Treatment of Sickle Cell Disease Using Antisense Oligonucleotides by Peralta, Raechel, Low, Audrey, Booten, Sheri, Zhou, Dewang, Kim, Aneeza, Freier, Sue, Guo, Shuling, Murray, Sue, Townes, Tim M., Hung, Gene

    Published in Blood (06-12-2014)
    “…Sickle cell anemia (SCD) is a hereditary blood disorder in which red blood cells (RBC) become sickle-shaped and block blood vessels, leading to painful…”
    Get full text
    Journal Article
  8. 8

    Targeting BCL11A and KLF1 For The Treatment Of Sickle Cell Disease and β-Thalassemia In Vitro using Antisense Oligonucleotides by Peralta, Raechel, Low, Audrey, Kim, Aneeza, Murray, Sue, Guo, Shuling, Freier, Sue, Townes, Tim M., Hung, Gene

    Published in Blood (15-11-2013)
    “…Sickle cell anemia (SCD) is a hereditary blood disorder in which red blood cells (RBC) become sickle-shaped and block blood vessels, leading to painful…”
    Get full text
    Journal Article
  9. 9

    Pharmacokinetic properties of 2'-O-(2-methoxyethyl)-modified oligonucleotide analogs in rats by Geary, R S, Watanabe, T A, Truong, L, Freier, S, Lesnik, E A, Sioufi, N B, Sasmor, H, Manoharan, M, Levin, A A

    “…Plasma pharmacokinetics, biodistribution, excretion, and metabolism of four modified 20-mer antisense oligonucleotides targeted to human intercellular adhesion…”
    Get more information
    Journal Article
  10. 10

    Reducing TMPRSS6 ameliorates hemochromatosis and [Beta]-thalassemia in mice by Guo, Shuling, Casu, Carla, Gardenghi, Sara, Booten, Sheri, Aghajan, Mariam, Peralta, Raechel, Watt, Andy, Freier, Sue, Monia, Brett P, RiveIla, Stefano

    Published in The Journal of clinical investigation (01-04-2013)
    “…β-Thalassemia and HFE-related hemochromatosis are 2 of the most frequently inherited disorders worldwide. Both disorders are characterized by low levels of…”
    Get full text
    Journal Article
  11. 11

    A Sense Oligonucleotide Specifically Reverses the Prothrombin Depletion and Anticoagulation Caused by ISIS 401025, an Antisense Oligonucleotide Targeting Prothrombin RNA in Mice by Zhao, Chenguang, Monia, Brett P., Siwkowski, Andy, Freier, Sue, Witchell, Donna, Zhang, Hong

    Published in Blood (16-11-2007)
    “…The ability to safely and effectively neutralize anticoagulant activity is of particular importance in the case of long acting drugs. While antisense…”
    Get full text
    Journal Article
  12. 12

    Antisense Strategies to Specifically Deplete Levels of Factors II, VII and IX in Mice To Assess Their Potential as Targets for Anticoagulation by Zhang, Hong, Zhao, Chenguang, Crosby, Jeff, Siwkowski, Andy, Freier, Sue, Witchell, Donna, Monia, Brett P.

    Published in Blood (16-11-2007)
    “…Numerous potential intervention points exist within coagulation pathways for development of novel anticoagulant agents. To help determine the most suitable…”
    Get full text
    Journal Article
  13. 13

    Artificial neural network prediction of antisense oligodeoxynucleotide activity by Giddings, Michael C., Shah, Atul A., Freier, Sue, Atkins, John F., Gesteland, Raymond F., Matveeva, Olga V.

    Published in Nucleic acids research (01-10-2002)
    “…An mRNA transcript contains many potential antisense oligodeoxynucleotide target sites. Identifi cation of the most efficacious targets remains an important…”
    Get full text
    Journal Article